MDCX

insider transactions

Medicus Pharma Ltd. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 3, 26

Andrew Alasdair Smith

Chief Operating Officer

$0

200.0K sh

Own New
Grant·A
Jun 3, 26

Cathy Mcmorris Rodgers

Director

$0

50.0K sh

Own New
Grant·A
Jun 3, 26

Ajay Raju

Director

$0

50.0K sh

Own New
Grant·A
Jun 3, 26

Faisal Mehmud

Chief Medical Officer

$0

250.0K sh

Own New
Grant·A
Jun 3, 26

Sara R. May

Director

$0

50.0K sh

Own New
Grant·A
Jun 3, 26

Patrick J Mahaffy

Director

$0

50.0K sh

Own New
Grant·A
Jun 3, 26

Larry Kaiser

Director

$0

50.0K sh

Own New
Grant·A
Jun 3, 26

Barry Fishman

Director

$0

50.0K sh

Own New
Grant·A
Jun 3, 26

Robert J. Ciaruffoli

Director

$0

50.0K sh

Own New
Grant·A
Jun 3, 26

Edward J. Brennan

Chief Scientific Officer

$0

25.0K sh

Own New
Grant·A
Jun 3, 26

Carolyn F. Bonner KEY

President and CFO

$0

250.0K sh

Own New
Grant·A
Jun 3, 26

Raza Bokhari KEY

Chief Executive Officer

$0

500.0K sh

Own New
Grant·A
Jun 3, 26

William Ashton

Director

$0

50.0K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 3, 2026	Andrew Alasdair Smith	Chief Operating Officer	Grant A	200.0K	New	—	$0
Jun 3, 2026	Cathy Mcmorris Rodgers	Director	Grant A	50.0K	New	—	$0
Jun 3, 2026	Ajay Raju	Director	Grant A	50.0K	New	—	$0
Jun 3, 2026	Faisal Mehmud	Chief Medical Officer	Grant A	250.0K	New	—	$0
Jun 3, 2026	Sara R. May	Director	Grant A	50.0K	New	—	$0
Jun 3, 2026	Patrick J Mahaffy	Director	Grant A	50.0K	New	—	$0
Jun 3, 2026	Larry Kaiser	Director	Grant A	50.0K	New	—	$0
Jun 3, 2026	Barry Fishman	Director	Grant A	50.0K	New	—	$0
Jun 3, 2026	Robert J. Ciaruffoli	Director	Grant A	50.0K	New	—	$0
Jun 3, 2026	Edward J. Brennan	Chief Scientific Officer	Grant A	25.0K	New	—	$0
Jun 3, 2026	Carolyn F. Bonner KEY	President and CFO	Grant A	250.0K	New	—	$0
Jun 3, 2026	Raza Bokhari KEY	Chief Executive Officer	Grant A	500.0K	New	—	$0
Jun 3, 2026	William Ashton	Director	Grant A	50.0K	New	—	$0

About MDCX insider trading

This page tracks insider transactions for Medicus Pharma Ltd. (MDCX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.